Publication & Citation Trends
Most Cited Works
Publications
167 total
MAGE-A Inhibits Apoptosis in Proliferating Myeloma Cells through Repression of Bax and Maintenance of Survivin PDF
Cited by 88
OpenAlex
Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma PDF
Cited by 116
OpenAlex
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma. PDF
Cited by 183
OpenAlex
Lenalidomide‐induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment‐naïve patients undergoing front‐line lenalidomide and dexamethasone therapy PDF
Cited by 89
OpenAlex
Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity
Cited by 302
OpenAlex
Research Topics
Multiple Myeloma Research and Treatments
(121)
Protein Degradation and Inhibitors
(45)
Cancer Treatment and Pharmacology
(27)
Hematopoietic Stem Cell Transplantation
(17)
CAR-T cell therapy research
(17)
Frequent Co-Authors
Affiliations
St. Luke's-Roosevelt Hospital Center
Memorial Sloan Kettering Cancer Center
NewYork–Presbyterian Hospital
Howard Hughes Medical Institute
Harvard University